News
Roche launches new innovation center in Boston
The Roche Genentech Innovation Center Boston has launched at Harvard’s Enterprise Research Campus in Allston, strengthening a long-standing partnership in areas such as disease...
U.S. FDA approves ARS Pharmaceuticals’ neffy 1 mg as needle-free epinephrine treatment for younger children
The U.S. Food and Drug Administration (FDA) has approved ARS Pharmaceuticals' neffy 1 mg (epinephrine nasal spray) for the treatment of Type I Allergic Reactions, including...
TEVIMBRA approved in U.S. for first-line treatment of advanced esophageal squamous cell carcinoma in...
The U.S. Food and Drug Administration (FDA) has approved BeiGene's TEVIMBRA (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the first-line treatment of adults with...
